TCA
ALXN
Taconic Capital Advisors’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-1,481,000
| Closed | -$272M | – | 548 |
|
|
2021
Q2 | $272M | Buy |
1,481,000
+501,000
| +51% | +$92M | 6.57% | 1 |
|
|
2021
Q1 | $150M | Buy |
+980,000
| New | +$150M | 4.74% | 3 |
|
|
2020
Q1 | – | Sell |
-30,000
| Closed | -$3.25M | – | 69 |
|
|
2019
Q4 | $3.25M | Buy |
+30,000
| New | +$3.25M | 0.13% | 30 |
|